Stock Futures Drop, Pointing to Retreat in Technology Shares
This is not a CAPTIS article. Originally, it was published here.
Dynavax secures EC marketing authorisation for hepatitis B vaccine This is not a CAPTIS article. Originally, it was published here.
Dynavax secures EC marketing authorisation for hepatitis B vaccine